intel confirms nova lake and bartlett lake-s processor families in tcc roadmap

Intel´s latest TCC Experience presentation reveals new details about the upcoming Nova Lake and pure P-core Bartlett Lake-S CPU families, designed for advanced real-time and edge computing tasks.

Intel has quietly disclosed key details about its future processor roadmaps in a publicly released ´Real-Time Gold Deck´ presentation focused on Time Coordinated Computing (TCC). Spotted by InstLatX64, the presentation—revision dated September 2024—catalogs both current and developing CPU platforms equipped to handle combined real-time and standard workloads. The documentation targets edge applications where latency, timing, and workload segregation are critical, underscoring platform enhancements achieved through both hardware and software optimizations.

A significant revelation from the TCC support slide is the official confirmation of Intel´s next-generation ´Nova Lake-S´ desktop and ´Nova Lake-U´ mobile processors. These processors have previously only been the subject of leaks and speculation, with recent findings pointing toward the use of the LGA 1954 socket standard. Intel is aiming for a 2026 launch window for the Nova Lake lineup, signaling a long-term roadmap for its advanced desktop and mobile processor strategy.

The same roadmap validates the existence of a pure P-core ´Bartlett Lake-S´ CPU family, with rumors tying it to a 12-core gaming configuration compatible with the LGA 1700 socket. The TCC Experience slide places Bartlett Lake-S ahead of the anticipated Panther Lake launch, under the branding of ´Intel Core Series 2.´ Within this timeline, the Bartlett Lake-S 12P category is listed just above the new ´Wildcat Lake´ low-end mobile series, which seems focused on maximizing power efficiency for entry-level applications. These developments demonstrate Intel´s multi-pronged approach: advancing high-performance desktop and mobile processors for both real-time and traditional usage scenarios, with clear segmentation for high-end, mainstream, and power-efficient use cases.

63

Impact Score

HMS researchers design Artificial Intelligence tool to quicken drug discovery

Harvard Medical School researchers unveiled PDGrapher, an Artificial Intelligence tool that identifies gene target combinations to reverse disease states up to 25 times faster than current methods. The Nature-published study outlines a shift from single-target screening to multi-gene intervention design.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.